895519-90-1

Basic information

• Product Name: BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-
• Synonyms: BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-;4-[(4-Methyl-1-piperazinyl)methyl]-N-[6-methyl-5-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-3-pyridinyl]-3-(trifluoromethyl)benzamide
• CAS NO: 895519-90-1
• Molecular Formula: C₂₉H₂₉F₃N₈O
• Molecular Weight: 562.5887696
• Product Categories: API
• Mol File: 895519-90-1.mol
• Article Data: 3

Chemical Properties

• Appearance: /
• CAS DataBase Reference: BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-(CAS DataBase Reference)
• NIST Chemistry Reference: BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-(895519-90-1)
• EPA Substance Registry System: BenzaMide, 4-[(4-Methyl-1-piperazinyl)Methyl]-N-[6-Methyl-5-[[4-(3-pyridinyl)-2-pyriMidinyl]aMino]-3-pyridinyl]-3-(trifluoroMethyl)-(895519-90-1)

Safety Data

• Hazardous Substances Data: 895519-90-1(Hazardous Substances Data)

Upstream product

• 109-01-3 1-methyl-piperazine 
• 261952-06-1 4-methyl-3-(trifluoromethyl)benzonitrile 
• 859027-02-4 4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl) benzoic acid 
• 895519-81-0 2-methyl-5-amino-3-(4-pyridin-3-yl)pyrimidin-2-ylamino-pyridine 

Downstream Products

• 1312165-54-0 N-desmethyl flumatinib 

Relevant articles and documents

Synthesis method of flumatinib

The invention discloses a synthesis method of flumatinib mesylate. The flumatinib is prepared by taking 4-methyl-3-(trifluoromethyl) cyanobenzene as an initial raw material through three steps of reactions of bromination, substitution and coupling. The me

AMINOPYRIMIDINE COMPOUNDS AND THEIR SALTS, PROCESS FOR PREPARATION AND PHARMACEUTICAL USE THEREOF

The present invention provides aminopyrimidine compounds of formula (I) and their salts, wherein R1, R2, R3, R4, R5, R6, Q, Z, L, m, n are defined as the description, the methods for preparation thereof, the uses thereof and the pharmaceutical compositions comprising the effective amount of compounds of formula (I). The compounds of formula (I) and their salts can be used as protein kinase inhibitors.